FOR IMMEDIATE RELEASE
Studies show potential use as a dietary supplement.
LIBERTYVILLE, IL., March 6, 2012 – Sumitomo Biorational Corporation announced today it has filed worldwide patent applications claiming beneficial health effects of abscisic acid (S-ABA) in humans and animals. S-ABA is a naturally occurring substance found in all plants, including fruits and vegetables.
The patent applications disclose data that could support further research for S-ABA as a therapeutic treatment or dietary supplement.
“VBC is the only global manufacturer and marketer of S-ABA and we’re excited to be actively exploring potential commercial opportunities for the molecule in a variety of markets,” said Dr. Warren E. Shafer, Sumitomo Biorational’ Vice President of Global Research & Development and Regulatory Affairs.
The filings are part of a series of global patents and patent applications related to S-ABA sought by the Illinois-based biotechnology company, which has commercialized two S- ABA products for crop use in the last three years. ProTone® Plant Growth Regulator was launched in 2009 to enhance color in table grapes, while BioNikTM Plant Growth Regulator is being launched in 2012 as a seed treatment to extend the window of pollen shed in hybrid corn seed production.
###
About Sumitomo Biorational Corporation
Headquartered in Libertyville, IL, Sumitomo Biorational is a subsidiary of Tokyo-based Sumitomo Chemical Company. Sumitomo Biorational is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in 95 countries around the world. Sumitomo Biorational is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.sumitomobiorational.com.
Barbara Wendling
847-968-4793
Email: barbara.wendling@valentbiosciences.com